1. Home
  2. INAB vs CNEY Comparison

INAB vs CNEY Comparison

Compare INAB & CNEY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INAB
  • CNEY
  • Stock Information
  • Founded
  • INAB 2016
  • CNEY 2018
  • Country
  • INAB United States
  • CNEY China
  • Employees
  • INAB N/A
  • CNEY N/A
  • Industry
  • INAB Biotechnology: Pharmaceutical Preparations
  • CNEY Major Chemicals
  • Sector
  • INAB Health Care
  • CNEY Industrials
  • Exchange
  • INAB Nasdaq
  • CNEY Nasdaq
  • Market Cap
  • INAB 8.7M
  • CNEY 8.0M
  • IPO Year
  • INAB 2021
  • CNEY 2021
  • Fundamental
  • Price
  • INAB $2.10
  • CNEY $2.34
  • Analyst Decision
  • INAB Strong Buy
  • CNEY
  • Analyst Count
  • INAB 2
  • CNEY 0
  • Target Price
  • INAB $108.00
  • CNEY N/A
  • AVG Volume (30 Days)
  • INAB 52.4K
  • CNEY 372.1K
  • Earning Date
  • INAB 11-11-2025
  • CNEY 01-01-0001
  • Dividend Yield
  • INAB N/A
  • CNEY N/A
  • EPS Growth
  • INAB N/A
  • CNEY N/A
  • EPS
  • INAB N/A
  • CNEY N/A
  • Revenue
  • INAB N/A
  • CNEY $50,957,974.00
  • Revenue This Year
  • INAB N/A
  • CNEY N/A
  • Revenue Next Year
  • INAB N/A
  • CNEY N/A
  • P/E Ratio
  • INAB N/A
  • CNEY N/A
  • Revenue Growth
  • INAB N/A
  • CNEY N/A
  • 52 Week Low
  • INAB $1.91
  • CNEY $1.56
  • 52 Week High
  • INAB $16.70
  • CNEY $31.75
  • Technical
  • Relative Strength Index (RSI)
  • INAB 43.89
  • CNEY 51.98
  • Support Level
  • INAB $1.91
  • CNEY $1.56
  • Resistance Level
  • INAB $2.26
  • CNEY $2.57
  • Average True Range (ATR)
  • INAB 0.11
  • CNEY 0.30
  • MACD
  • INAB -0.01
  • CNEY 0.01
  • Stochastic Oscillator
  • INAB 48.72
  • CNEY 71.76

About INAB IN8bio Inc.

IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous, and genetically modified gamma-delta T cells. Its product candidates include INB-400, for the treatment of newly diagnosed glioblastoma, or GBM, INB-100 for the treatment of patients with high-risk leukemias undergoing hematopoietic stem cell transplantation, and other product candidates such as INB-200, INB-300, and INB-500.

About CNEY CN Energy Group Inc.

CN Energy Group Inc along with its subsidiaries is a manufacturer and supplier of wood-based activated carbon that is used in pharmaceutical manufacturing, industrial manufacturing, water purification, environmental protection, and food and beverage production and a producer of biomass electricity generated in the process of producing activated carbon. The firm generates a majority of its revenue from Activated carbon.

Share on Social Networks: